October 7, 2021
UC San Diego study suggests multisystem inflammatory syndrome in children (MIS-C), a rare condition associated with COVID-19, is not caused by abnormal T cell response to COVID-19 virus as previously hypothesized.
September 20, 2022
A national team of scientists, led by researchers at UC San Diego, have created a machine-learning algorithm for diagnosing both MIS-C and Kawasaki disease, two similar pediatric inflammatory conditions with different treatments.
September 23, 2013
After more than four decades of research, strong evidence now shows that Kawasaki disease has a distinct seasonal occurrence shared by regions across the Northern hemisphere.
May 19, 2014
An international team of scientists, including researchers from the University of California, San Diego, report that the likely causative agent of Kawasaki disease (KD) in Japan is a windborne agent originating from a source in northeast China. KD is a mysterious childhood ailment that can permanently damage coronary arteries.
November 10, 2011
Kawasaki Disease (KD) is a severe childhood disease that many parents, even some doctors, mistake for an inconsequential viral infection. In fact, if not diagnosed or treated in time, it can lead to irreversible heart damage. After 50 years of research, including genetic studies, scientists have been unable to pinpoint…
October 26, 2021
Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.
July 2, 2020
Historical Disease Meets Modern Biology in New Faculty Member Cressida Madigan’s Lab New Biological Sciences faculty member Cressida Madigan doesn’t mind if an ancient disease such as leprosy is not something we think about every day. Influenced by her art historian parents and diseases that changed the course of world…
September 10, 2013
In the years since the best-selling book “The Immortal Life of Henrietta Lacks” made the issue of informed consent and patient privacy a national topic of conversation, scientists and clinicians have continued to struggle to develop a comprehensive methodology for collecting and sharing data from patients and research subjects without…
August 5, 2022
Brookie Best, PharmD, has been named the next dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, succeeding James McKerrow, PhD, MD, who stepped down June 30, 2022.
February 25, 2021
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.
